Author:
Demirelli Erhan,Haliloğlu Ahmet Hakan,Gülpınar Ömer,Sönmez Mehmet Giray,Bedük Yaşar,Küpeli Sadettin
Reference30 articles.
1. 1. Griffin JE, Wilson JD. Disorders of the testis and the male reproductive tract. In: Wilson JD editor. Williams Textbook of Endocrinology. Philadelphia: Saunders Company;1998. P. 819-75.
2. 2. Akdoğan B, Özen H. Benign prostatic hypertrophy and prostate cancer after testosterone replacement therapy. Bull Urooncol. 2006;5:3-6.
3. 3. Labrie F. Medical castration with LHRH agonists: 25 years later with major benefits achieved on survival in prostate cancer. J Androl. 2004;25:305–13.
4. 4. Huggins C, Stevens RE Jr, Hodges CV. Studies on prostate cancer. II. The effect of castration on advanced carcinoma of the prostate gland. Arch Surg 1941;43:209-23.
5. 5. Iversen P, Tyrrell CJ, Kaisary AV, Anderson JB, Van Poppel H, Tammela TL, et al. Bicalutamide monotherapy compared with castration in patients with nonmetastatic locally advanced prostate cancer: 6.3 years of follow up. J Urol. 2000;164:1579–82.